[go: up one dir, main page]

CO5070569A1 - COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM - Google Patents

COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM

Info

Publication number
CO5070569A1
CO5070569A1 CO99031508A CO99031508A CO5070569A1 CO 5070569 A1 CO5070569 A1 CO 5070569A1 CO 99031508 A CO99031508 A CO 99031508A CO 99031508 A CO99031508 A CO 99031508A CO 5070569 A1 CO5070569 A1 CO 5070569A1
Authority
CO
Colombia
Prior art keywords
compound
aminoazol
pharmaceutically acceptable
acceptable salt
same
Prior art date
Application number
CO99031508A
Other languages
Spanish (es)
Inventor
Peter Buhlmayer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO5070569A1 publication Critical patent/CO5070569A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con un compuesto de la fórmula (I):<EMI FILE="99031508_1" ID="1" IMF=JPEG >o una sal de el mismo, métodos para su preparación y composiciones farmacéuticas que los contienen.The present invention relates to a compound of the formula (I): <EMI FILE = "99031508_1" ID = "1" IMF = JPEG> or a salt thereof, methods for its preparation and pharmaceutical compositions containing them.

CO99031508A 1998-05-29 1999-05-21 COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM CO5070569A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1998124175 DE19824175A1 (en) 1998-05-29 1998-05-29 Amino azole compounds

Publications (1)

Publication Number Publication Date
CO5070569A1 true CO5070569A1 (en) 2001-08-28

Family

ID=7869385

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99031508A CO5070569A1 (en) 1998-05-29 1999-05-21 COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM

Country Status (4)

Country Link
AU (1) AU4501699A (en)
CO (1) CO5070569A1 (en)
DE (1) DE19824175A1 (en)
WO (1) WO1999062892A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191160B1 (en) 1998-11-10 2001-02-20 Merck & Co., Inc. Spiro-indolines as Y5 receptor antagonists
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
EP1816127A1 (en) 1999-04-22 2007-08-08 H. Lundbeck A/S Triazine derivatives for use as selective npy (y5) antagonists
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
WO2001017995A1 (en) 1999-09-10 2001-03-15 Merck & Co., Inc. Tyrosine kinase inhibitors
AU2001246494A1 (en) * 2000-03-03 2001-09-12 Novartis Ag Condensed thiazolamines and their use as neuropeptide y5 antagonists
CA2450562A1 (en) 2001-06-22 2003-01-03 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2003051356A1 (en) * 2001-12-17 2003-06-26 Merck & Co., Inc. Method for treating circadian rhythm disruptions
JP2005526732A (en) 2002-02-28 2005-09-08 エフ．ホフマン−ラ　ロシュ　アーゲー Thiazole derivatives as NPY receptor antagonists
US6872724B2 (en) 2002-07-24 2005-03-29 Merck & Co., Inc. Polymorphs with tyrosine kinase activity
CA2493712A1 (en) * 2002-08-07 2004-02-19 F. Hoffmann-La Roche Ag Aminothiazole derivatives as npy5 receptor inhibitors
AU2004263312A1 (en) 2003-08-12 2005-02-17 F. Hoffmann-La Roche Ag Thiazole derivatives as NPY antagonists
AU2004263311A1 (en) 2003-08-12 2005-02-17 F. Hoffmann-La Roche Ag 2-amino-5-benzoylthiazole NPY antagonists
AR081626A1 (en) 2010-04-23 2012-10-10 Cytokinetics Inc AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (en) 2010-04-23 2012-08-08 Cytokinetics Inc AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326465A1 (en) * 1993-01-20 1995-02-09 Thomae Gmbh Dr K Amino acid derivatives, pharmaceutical compositions containing these compounds and process for their preparation
DE19544687A1 (en) * 1995-11-30 1997-06-05 Thomae Gmbh Dr K Amino acid derivatives, medicaments containing these compounds and processes for their preparation
AU7692696A (en) * 1995-12-01 1997-06-27 Novartis Ag Heteroaryl derivatives
TW399051B (en) * 1996-01-31 2000-07-21 Ssp Co Ltd A novel benzoazine thiazolidinedione derivative and pharmaceutical composition for reducing blood glucose
TR199902442T2 (en) * 1997-01-28 2000-07-21 Merck & Co.,Inc. Thiazole benzenesulfonamides as β3 agonists in the treatment of sugar and obesity.
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
WO1999062892A1 (en) 1999-12-09
AU4501699A (en) 1999-12-20
DE19824175A1 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
CO5070569A1 (en) COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM
AR037517A1 (en) DERIVATIVES OF NAFTIRIDINES, A PROCESS FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AN INFLAMMATORY DISEASE
CO4290417A1 (en) NEW BENZOYLGUANIDINES AS MEDICINES AND THEIR PREPARATION.
AR066982A2 (en) HETEROAROMATIC COMPOUNDS REPLACED AS INHIBIDORESS TIROSIN QUINASA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF MEDICINES
AR004700A1 (en) 1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT
AR022008A1 (en) A COMPOSITION OF CONTROLLED GALANTAMINE RELEASE, A PROCESS FOR THE PREPARATION OF THE SAME, AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT
ES2076935T3 (en) COMPOUND OF PIRAZOLOPYRIDINE AND PROCEDURES FOR ITS PREPARATION.
EP1362846A4 (en) AMINOETHANOLDERIVATE
CO4940450A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE
MX9202166A (en) DERIVATIVES OF AMIDINO FENIL ALANINA, PROCEDURE FOR ITS PREPARATION, ITS EMPLOYMENT AND AGENTS THAT CONTAIN THEM AS ANTICOAGULANT.
ES2157314T3 (en) TRICICLIC DERIVATIVES AND ITS USE IN PHARMACEUTICAL PRODUCTS.
IS1664B (en) New method of producing substituted 4-phenyl-4-piperidinecarboxamide which has both local anesthetic and analgesic effect
ES2095976T3 (en) PIRAZOLOPYRIDINE COMPOUNDS AND PROCEDURE FOR THE PREPARATION.
AR025052A1 (en) DERIVATIVES OF 2-DIALQUILAMINOALQUILBIFENILO SUBSTITUTED, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THE USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES.
AR019496A1 (en) AZALIDAS OF 13 MEMBERS, PHARMACEUTICAL COMPOSITIONS, USE IN THE PREPARATION OF MEDICINES AND PREPARATION OF THE SAME
PT1233953E (en) NEW BENZOTIADIAZIN DERIVATIVES PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
NO972623D0 (en) Formula mixture comprising lamotrigine
ES2110115T3 (en) PLATELET AGGREGATION INHIBITORS.
ES2194933T3 (en) INHIBITORS OF THE PLAQUETARY AGGREGATION.
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
DK0701449T3 (en) Process for the preparation of an oral solid dosage form containing diclofenac
AR035006A1 (en) DERIVATIVE OF NAFTIRIDIN-DIBENZO [A, D] CICLOHEPTENO-10-ACETICO, PHARMACEUTICAL COMPOSITION, AND THE USE OF THAT DERIVATIVE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.
IT9019793A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
CO5160291A1 (en) PHARMACEUTICAL COMPOSITION TOPICA CONTAINING 4- (2,4-DIHYDROXIFENIL) CYCLHEXANOL
AR002191A1 (en) ORAL PHARMACEUTICAL COMPOSITION OF PIPERIDINOALCANOL COMPOUNDS IN THE FORM OF SOLUTION, PROCEDURE FOR ITS PREPARATION